Theratechnologies inc.

Theratechnologies inc.

March 27, 2007 09:55 ET

Media Advisory/Theratechnologies: Annual General Meeting of Shareholders

MONTREAL, QUEBEC--(CCNMatthews - March 27, 2007) - Mr. A. Jean de Grandpre, Chairman of the Board of Theratechnologies (TSX:TH) and Mr. Yves Rosconi, President and Chief Executive Officer, invite shareholders and members of the media to Theratechnologies' Annual General Meeting of Shareholders that will be held on Thursday, March 29, 2007, at 10:00 am, at the Centre Mont-Royal, 2200 Mansfield Street, in Montreal.

Business and financial media representatives are invited to meet members of Theratechnologies' management at 11:00 am, at the close of the meeting.

What: Annual General Meeting of Shareholders of Theratechnologies

When: Thursday, March 29, 2007
Annual meeting at 10:00 am
Meeting with media representatives at 11:00 am

Where: Centre Mont-Royal
2200 Mansfield Street (corner of Sherbrooke Street)
Salon international

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers or acquires innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in financially attractive specialty markets. Its most advanced program is TH9507, now in Phase 3 clinical trials for a serious metabolic disorder known as HIV-associated lipodystrophy. The Company also has other promising projects at earlier stages of development.

Contact Information

  • Theratechnologies
    Yves Rosconi
    President and Chief Executive Officer
    514-336-4804, ext. 221